You are not logged in.
This means you
CAN ONLY VIEW reports that were published prior to Sunday, October 20, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
AFTER MARKET UPDATE - MONDAY, OCTOBER 24TH, 2022
Previous After Market Report Next After Market Report >>>
|
|
|
|
DOW |
+417.06 |
31,499.62 |
+1.34% |
|
Volume |
986,883,635 |
-19% |
|
Volume |
4,822,084,900 |
+2% |
|
NASDAQ |
+92.90 |
10,952.61 |
+0.86% |
|
Advancers |
1,753 |
57% |
|
Advancers |
2,252 |
49% |
|
S&P 500 |
+44.59 |
3,797.34 |
+1.19% |
|
Decliners |
1,310 |
43% |
|
Decliners |
2,327 |
51% |
|
Russell 2000 |
+6.16 |
1,748.40 |
+0.35% |
|
52 Wk Highs |
66 |
|
|
52 Wk Highs |
68 |
|
|
S&P 600 |
+9.49 |
1,137.03 |
+0.84% |
|
52 Wk Lows |
333 |
|
|
52 Wk Lows |
446 |
|
|
More convincing gains on Friday helped the market (M criteria) signal a new uptrend with a follow-through day.
|
 |
Leadership Improved Behind Major Indices' Gains
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
The Dow added 417 points, while the Nasdaq Composite advanced 0.9% ahead of this week’s earnings from technology giants. The S&P 500 climbed 1.2%.The volume totals reported were mixed, lighter than the prior session on the NYSE and higher on the Nasdaq exchange. Advancers led decliners by a 4-3 margin on the NYSE while decliners narrowly led advancers on the Nasdaq exchange. Leadership improved as there were 38 high-ranked companies from the Leaders List that hit new 52-week highs and were listed on the BreakOuts Page, more than doubling the total of 17 on the prior session. New 52-week lows totals still outnumbered new 52-week highs totals on both the NYSE and the Nasdaq exchange. The follow-through day on Friday helped establish a confirmed uptrend (M criteria). Healthy leadership (new 52-week highs totals) will be essential in the near-term for the rally to be productive.
Chart courtesy of www.stockcharts.com PICTURED: The Nasdaq Composite Index posted a gain with lighter volume, rising above the August-October downward trendline. Only stocks meeting all key-criteria of the fact-based investment system should be considered as buy candidates.
U.S. equities climbed Monday as investors look ahead to a busy week of corporate earnings with 165 companies reporting. Meanwhile, the S&P 500 composite reported approximately 4% of it stocks broke a new 52-week high during trading. Nine of the 11 S&P 500 sectors closed in positive territory, with Health Care leading gains.
On the data front, the S&P Global US Manufacturing Purchasing Managers’ Index (PMI) came in lower than expected at 49.9, sliding into contraction territory in October marking its lowest point in 28 months. The S&P Global US Services PMI unexpectedly fell to 46.6 from September’s 49.3 print.
Treasury yields increased as investors weigh the future outcome of the Federal Reserve’s (Fed’s) November meeting. The yield on the benchmark 10-year note gained three basis points (0.03%) to 4.25%, while the yield on the 30-year bond increased seven basis points (0.07%) to 4.40%. The more policy-sensitive two-year note yield added four basis points (0.04%) to 4.52%. In commodities, West Texas Intermediate (WTI) crude slipped 0.4% to $84.75/barrel amid disappointing data from China. China’s crude imports in September were down 2% from a year earlier as the country’s zero-COVID policy weighed on oil demand. The U.S. Dollar Index remained unchanged despite reports from Friday suggesting the Fed may implement a smaller interest rate hike at their December policy meeting.
|
Kenneth J. Gruneisen started out as a licensed stockbroker in August 1987, a couple of months prior to the historic stock market crash that took the Dow Jones Industrial Average down -22.6% in a single day. He has published daily fact-based fundamental and technical analysis on high-ranked stocks online for two decades. Through FACTBASEDINVESTING.COM, Kenneth provides educational articles, news, market commentary, and other information regarding proven investment systems that work in good times and bad.
Comments contained in the body of this report are technical opinions only and are not necessarily those of Gruneisen Growth Corp. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. Our firm, employees, and customers may effect transactions, including transactions contrary to any recommendation herein, or have positions in the securities mentioned herein or options with respect thereto. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. |
|
 |
Retail, Financial, Tech, and Energy-Linked Groups Rose
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
The Retail Index ($RLX +1.48%) and Bank Index ($BKX +1.76%) both posted influential gains while the Broker/Dealer Index ($XBD +0.63%) also edged higher.. The Semiconductor Index ($SOX +0.64%), Networking Index ($NWX +0.59%), and Biotech Index ($BTK +0.59%) each posted a small gain. The Oil Services Index ($OSX +1.48%) posted a solid gain and the Integrated Oil Index ($XOI +0.12%) inched higher but the Gold & Silver Index ($XAU -1.27%) lost ground.
PICTURED: The Retail Index ($RLX +1.48%) remains below its 50-day moving average (DMA) line.
| Oil Services |
$OSX |
77.41 |
+1.13 |
+1.48% |
+46.84% |
| Integrated Oil |
$XOI |
1,795.48 |
+2.17 |
+0.12% |
+52.39% |
| Semiconductor |
$SOX |
2,351.55 |
+14.86 |
+0.64% |
-40.41% |
| Networking |
$NWX |
793.68 |
+4.64 |
+0.59% |
-18.27% |
| Broker/Dealer |
$XBD |
435.83 |
+2.72 |
+0.63% |
-10.48% |
| Retail |
$RLX |
3,128.50 |
+45.66 |
+1.48% |
-25.98% |
| Gold & Silver |
$XAU |
102.38 |
-1.31 |
-1.27% |
-22.70% |
| Bank |
$BKX |
100.58 |
+1.74 |
+1.76% |
-23.93% |
| Biotech |
$BTK |
4,709.69 |
+27.67 |
+0.59% |
-14.66% |
|
|
|
 |
Volume-Driven Gain Triggered Technical Buy Signal
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
Vertex Pharmaceuticals (VRTX +$10.50 or +3.50% to $310.50) was highlighted in yellow in the earlier mid-day report (read here) with pivot point cited based on its 8/15/22 high plus 10 cents. It hit a new 52-week high with today's gain above the pivot point backed by +56% above average volume triggering a proper technical buy signal.
VRTX has a highest possible 99 Earnings Per Share Rating. It reported greatly improved earnings on +22% sales revenues for the Jun '22 quarter versus the year-ago period, and 3 of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Its annual earnings (A criteria) history has been strong.
It hails from the Medical-Biomed/Biotech industry which is currently ranked 7th on the 197 Industry Groups list It has 256.5 million shares outstanding (S criteria). The number of top-rated funds owning its shares rose from 2,722 in Dec '21 to 3,215 in Sep '22, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 1.3 is an unbiased indication its shares have been under accumulation over the past 50 days. It has a Timeliness Rating of A ad Sponsorship Rating of B. |
|
|
Color Codes Explained :
Y - Better candidates highlighted by our
staff of experts.
G - Previously featured
in past reports as yellow but may no longer be buyable under the
guidelines.
***Last / Change / Volume data in this table is the closing quote data***
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(% 50 day avg vol) |
52 Wk Hi
% From Hi |
Featured
Date |
Price
Featured |
Pivot Featured |
|
Max Buy |
CI
-
NYSE
Cigna Corp
Medical-Managed Care
|
$306.95
|
+5.61
1.86% |
$308.28
|
1,875,126
95.77% of 50 DAV
50 DAV is 1,958,000
|
$302.29
1.54%
|
7/7/2022
|
$276.55
|
PP = $273.68
|
|
MB = $287.36
|
Most Recent Note - 10/21/2022 5:21:45 PM
G - Posted a gain today with near average volume for a new all-tie high. Its 50 DMA line ($288.62) defines near-term support to watch above the recent low ($283.79 on 10/10/22). Fundamental concerns also remain after the Jun '22 quarter rose +19% on +5% sales revenues versus the year ago period, breaking a streak of 3 quarterly earnings increases above the +25% minimum guideline (C criteria).
>>> FEATURED STOCK ARTICLE : No Resistance Remains Due to Overhead Supply - 10/4/2022 |
View all notes |
Set NEW NOTE alert |
Company Profile |
SEC
News |
Chart |
Request a new note
C
A
S
I |
ESQ
-
NASDAQ
Esquire Financial Hldgs
Finance-Commercial Loans
|
$39.82
|
+0.58
1.48% |
$40.50
|
40,848
157.11% of 50 DAV
50 DAV is 26,000
|
$41.68
-4.46%
|
10/18/2022
|
$40.02
|
PP = $39.95
|
|
MB = $41.95
|
Most Recent Note - 10/21/2022 5:24:32 PM
Y - Pulled back today with lighter (near average) volume for a 3rd consecutive loss after challenging its 52-week high. Posted a big gain on 10/18/22 and closed above the pivot point backed by +68% above average volume triggering a technical buy signal. Recent rebound above the 50 DMA line ($38.47) helped its outlook improve. Very little near-term resistance remains up to the $41.68 level.
>>> FEATURED STOCK ARTICLE : Rebound Above 50-Day Moving Average Needed for Outlook to Improve - 10/7/2022 |
View all notes |
Set NEW NOTE alert |
Company Profile |
SEC
News |
Chart |
Request a new note
C
A
S
I |
CCRN
-
NASDAQ
Cross Country Healthcare
DIVERSIFIED SERVICES - Staffing and Outsourcing Service
|
$37.06
|
+0.63
1.73% |
$38.46
|
1,264,019
144.13% of 50 DAV
50 DAV is 877,000
|
$36.50
1.53%
|
9/9/2022
|
$27.32
|
PP = $30.61
|
|
MB = $32.14
|
Most Recent Note - 10/21/2022 5:20:10 PM
G - Posted a big gain with higher (near average) volume for a new 52-week high. Prior highs in the $30.50 area define initial support to watch above its 50 DMA line ($28.28).
>>> FEATURED STOCK ARTICLE : Healthcare Staffing Firm Hovering Near All-Time High - 10/17/2022 |
View all notes |
Set NEW NOTE alert |
Company Profile |
SEC
News |
Chart |
Request a new note
C
A
S
I |
CMC
-
NYSE
Commercial Metals Co
METALS and MINING - Steel and Iron
|
$44.20
|
+0.35
0.80% |
$44.75
|
1,521,560
158.33% of 50 DAV
50 DAV is 961,000
|
$46.68
-5.31%
|
10/14/2022
|
$41.61
|
PP = $44.45
|
|
MB = $46.67
|
Most Recent Note - 10/21/2022 5:22:50 PM
Y - Posted a gain with +112% above average volume and closed above the pivot point triggering a technical buy signal. Faces very little resistance due to overhead supply up to the $46 level. Reported Aug '22 quarterly earnings +94% on +19% sales revenues versus the year ago period and prior quarterly comparisons were well above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings growth has been strong.
>>> FEATURED STOCK ARTICLE : Little Resistance Remains for Strong Steel/Metal Products Firm - 10/14/2022 |
View all notes |
Set NEW NOTE alert |
Company Profile |
SEC
News |
Chart |
Request a new note
C
A
S
I |
VRTX
-
NASDAQ
Vertex Pharmaceuticals
Medical-Biomed/Biotech
|
$310.50
|
+10.50
3.50% |
$312.27
|
1,993,751
158.86% of 50 DAV
50 DAV is 1,255,000
|
$305.95
1.49%
|
10/24/2022
|
$308.47
|
PP = $306.05
|
|
MB = $321.35
|
Most Recent Note - 10/24/2022 5:46:14 PM
Y - Highlighted in yellow with pivot point cited based on its 8/15/22 high pus 10 cents in the earlier mid-day report. Hit a new 52-week high with today's gain above the pivot point backed +58% above average volume triggering a proper technical buy signal. Reported greatly improved earnings on +22% sales revenues for the Jun '22 quarter versus the year-ago period, and 3 of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) history has been strong. See the latest FS analysis for more details and a new annotated graph.
>>> FEATURED STOCK ARTICLE : Volume-Driven Gain Triggered Technical Buy Signal - 10/24/2022 |
View all notes |
Set NEW NOTE alert |
Company Profile |
SEC
News |
Chart |
Request a new note
C
A
S
I |
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(% 50 day avg vol) |
52 Wk Hi
% From Hi |
Featured
Date |
Price
Featured |
Pivot Featured |
|
Max Buy |
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
This site is not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to Premium Membership Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 1-800-965-8307
or 954-785-1121.
|
|
|
